Neocalmans Retard

Quick links

Choose a section

Quick links to important sections

Advertisements

Neocalmans Retard

Advertisements
Advertisements

Overview of Neocalmans Retard

The following summary provides essential identity, classification, and design facts about Neocalmans Retard, excluding information related to dosage, usage instructions, or safety.

Property Description
Active ingredient Morphine sulfate
Form Prolonged-release tablet (Sustained-release)
Pharmacological class Opioid analgesic, Narcotic analgesic
General purpose Relief of severe, persistent pain requiring continuous treatment
Origin Semisynthetic (derived from natural opium alkaloids)

What Type of Medicine is Neocalmans Retard?

Neocalmans Retard is a prescription-only medication whose active component is morphine sulfate. It is classified as a potent opioid analgesic, belonging to the class of narcotic analgesics. This classification signifies its function as a centrally acting pain reliever, operating on the central nervous system to reduce the overall sensation of discomfort. Morphine itself is a semisynthetic substance, historically derived from the natural alkaloids found in the Papaver somniferum (opium poppy) plant. The medicine's primary purpose is to deliver strong relief for pain severity that requires continuous, high-level pharmacological intervention, often used in cases such as cancer-related pain.


The Significance of the Prolonged-Release Tablet Form

The medication is presented as a prolonged-release tablet, often designated by the term "Retard" or sustained-release formulation. This specific design is a type of modified-release dosage form that addresses a key clinical need by controlling the rate of the active ingredient's release over time. The sustained-release characteristic ensures that the morphine sulfate is gradually metered into the body across an extended duration, unlike immediate-release versions. The resulting benefit is the provision of continuous pain control, making it suitable for managing severe pain that requires consistent, round-the-clock management by maintaining stable therapeutic concentrations.

Regulatory References

  1. Morphine - StatPearls (NIH)
Advertisements

What side effects are possible with Neocalmans Retard?

Possible Side Effects and Safety Information

The safety profile of Neocalmans Retard, which contains morphine sulfate, is defined by effects categorized across different organ systems, as documented in official regulatory labeling. This prolonged-release formulation is associated with both common, expected adverse reactions and critical, serious risks.


Frequency and System-Organ Effects

Adverse reactions are classified based on the incidence reported in regulatory documents:

  • Very Common (ge 1/10): Constipation and Nausea are the most frequently reported gastrointestinal effects.
  • Common (ge 1/100 to < 1/10): This category includes Vomiting, Dry mouth, and effects on the nervous system such as Sedation, Dizziness, and Headache. Pruritus (itching) and Sweating are also commonly reported.
  • Uncommon (ge 1/1,000 to < 1/100): This group includes Respiratory depression, Orthostatic hypotension (a drop in blood pressure when standing), and Urinary retention.

Serious Adverse Reactions and Safety Constraints

The most significant and potentially life-threatening risk associated with potent opioids is Respiratory Depression. Official labeling also highlights Severe Hypotension and the risk of Neonatal Opioid Withdrawal Syndrome (NOWS) if the medicine is used for prolonged periods during pregnancy. The label formally restricts use in individuals with conditions such as severe respiratory compromise or paralytic ileus.

Exposure- and Population-Specific Notes

Certain effects are linked to duration of use: Tolerance and Physical Dependence are documented consequences of chronic administration. Furthermore, regulatory notes address specific populations, including the increased sensitivity to adverse effects, particularly respiratory depression, observed in older adults and the risk of accumulation in patients with renal impairment.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Neocalmans Retard focuses on the critical, life-threatening manifestations of overdose stemming from profound central nervous system (CNS) and respiratory depression. Documented clinical manifestations include excessive sleepiness progressing to stupor or coma, limp muscles (skeletal muscle flaccidity), and characteristically small (pinpoint) pupils. The most severe outcomes cited in regulatory labeling are respiratory arrest, cardiac arrest, and circulatory collapse.

When to Seek Immediate Medical Help

Any suspected overdose constitutes a medical emergency. Regulatory documents explicitly state that immediate medical attention must be sought if any signs of overdose are present. Urgent emergency services must be contacted immediately if symptoms include slowed or difficult breathing, long pauses between breaths, or if the patient cannot be roused or awakened.

Critical Risks and Official Management

The prolonged-release formulation presents a specific and critical risk: accidental ingestion of even a single tablet, particularly by a child, can result in a fatal overdose. Crushing, dissolving, or chewing the tablets causes the rapid release of a potentially fatal dose of the active ingredient. The documented intervention for severe overdose involves the administration of the specific opioid antagonist, naloxone. Due to the sustained-release design, continuous hospital monitoring is required to observe for the potential recurrence of symptoms after initial treatment.

Advertisements

Therapeutic Uses of Neocalmans Retard

What Neocalmans Retard Treats: Main Uses and Benefits

Neocalmans Retard is commonly used for managing severe pain and provides supportive relief for conditions defined by severe, persistent pain that requires sustained symptomatic management. This formulation is generally applied when alternative treatment options are inadequate.


Continuous Relief of Severe Chronic Pain

This medication is applied to address symptoms related to severe, ongoing physical discomfort that is expected to last for an extended duration, requiring a consistent therapeutic approach. Its prolonged-release formulation supports the key benefit of maintaining stable pain control, and may help patients cope more steadily with symptom fluctuations. This treatment is considered relevant in situations where less potent analgesics are inadequate.

Symptom Management in Advanced Conditions

It is commonly used in situations involving advanced, life-limiting conditions, where symptom control and patient comfort are considered relevant. It is applied across domains where additional symptomatic support is needed to manage intense and severe pain manifestations, such as cancer-related pain. This support helps improve day-to-day comfort and assists with maintaining functional stability during symptomatic phases.


Quick Fact: Relief for Severe, Persistent Pain

It is considered relevant in contexts involving sustained symptomatic management for pain that requires an extended treatment period, and provides supportive relief when symptoms interfere with daily functioning.

Advertisements

Eligibility and Restrictions for Use

The eligibility for Neocalmans Retard (morphine sulfate prolonged-release) is strictly defined by regulatory authorities based on a patient's clinical status and age. The medicine is primarily reserved for adult patients (typically 18+ years) who are opioid-tolerant and require continuous, around-the-clock pain management.


Populations Prohibited from Use (Contraindicated)

Use is strictly forbidden in patients with specific conditions, including:

  • Significant respiratory depression or acute/severe bronchial asthma.
  • Known or suspected gastrointestinal obstruction, such as paralytic ileus.
  • Known hypersensitivity to morphine or any component of the formulation.
  • Concurrent use of, or use within 14 days of discontinuing, Monoamine Oxidase Inhibitors (MAOIs).

Conditional Eligibility and Restrictions

Age-Related Rules: The medicine is contraindicated in infants (under one year of age). Use is not established for the wider pediatric population, and is not recommended in children under 12 years. Caution is required when treating elderly or debilitated patients.

Organ Function: Patients with severe hepatic or renal impairment require caution and may need a dosage reduction, as stated in official labeling.

Pregnancy and Lactation: Prolonged use during pregnancy can lead to Neonatal Opioid Withdrawal Syndrome (NOWS). Nursing is not recommended as the active substance is excreted into breast milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Neocalmans Retard (morphine sulfate prolonged-release) has formally documented interaction patterns that are classified by regulatory agencies based on the potential for adverse outcomes or modified drug effects.

Contraindicated and High-Risk Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated; a mandatory 14-day washout period is required after stopping MAOIs before initiating this medicine. Co-administration with alcohol must be strictly avoided as it can cause a rapid, potentially fatal release of the drug from the prolonged-release tablet. The use of certain opioid classes, specifically mixed agonist/antagonist or partial agonist opioids, should be avoided as they may reduce pain relief or precipitate withdrawal symptoms.

Pharmacodynamic and Exposure Interactions

Concomitant use with other Central Nervous System (CNS) depressants, including benzodiazepines, sedatives, and general anesthetics, is documented to result in additive CNS depression, increasing the risk of profound sedation. Combining this medicine with serotonergic drugs may lead to Serotonin Syndrome. Separately, substances such as Cimetidine and Ritonavir are noted to alter the plasma exposure of morphine. Caution is noted in patients with severe hepatic or renal impairment, as the rate of drug removal may be slower, potentially increasing morphine's effects.

Advertisements

Mechanism of Action

How Neocalmans Retard Works


The drug's core action is initiated by its full agonism at the mu-opioid receptor ( MOR), a G-protein coupled receptor abundant in the central nervous system. This direct molecular engagement activates a specific inhibitory cascade, contributing to the suppression of nociceptive signaling within the primary pathways.

Activation of the MOR triggers internal signaling that directly leads to the opening of Potassium ( K^+) channels and the inhibition of Voltage-gated Calcium ( Ca^2+) channels. This dual action hyperpolarizes the neuron and reduces the release of excitatory neurotransmitters, modifying early molecular steps that shape the systemic physiological outcome of signal suppression.

The overall mechanism results from a combination of spinal signal inhibition and the drug's action within the brain's limbic system, which alters signaling within these structures. However, this receptor-mediated process is constrained by biological limits, including pharmacodynamic tolerance (receptor desensitization) and opioid-induced hyperalgesia, which influence the persistence of the core mechanistic effect.

Advertisements

Dosage and Administration Information

How to Use Neocalmans Retard

Neocalmans Retard is administered orally and is strictly formulated as a prolonged-release tablet, designed for the continuous management of severe, persistent pain. This formulation is used for around-the-clock analgesic control, not for as-needed (PRN) relief.


Official Administration Principles

The fundamental principle for its use is the requirement to swallow the tablet whole. The tablets must not be crushed, chewed, or dissolved to prevent the rapid release of the entire dose, which would compromise the prolonged-release mechanism. The tablet may generally be taken with or without food.

Dosage and Frequency

The medication is typically taken at fixed 12-hourly intervals (twice daily) to maintain stable drug concentrations in the body. Dosing begins with a low starting strength and must be individually titrated (adjusted) over time based on patient need until effective, sustained pain control is achieved. Higher strengths (e.g., 100 mg or 200 mg) are intended only for patients who have established opioid tolerance.


Population-Specific Adjustments

Treatment in older adults or those with renal or hepatic impairment should commence with a reduced initial dosage due to potential changes in drug clearance and sensitivity. When discontinuing treatment after long-term use, the dose must be gradually tapered to avoid withdrawal symptoms.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Mechanism of Action and Core Findings

The core clinical research has focused on evaluating this drug. Studies evaluated symptom severity measures in patients with chronic inflammatory disease.

A key finding is that researchers examined the drug's potential to impact pain and quality of life. The timing of the observed response was noted in some studies.

The drug's impact was examined in mild to moderate cases. Some research explored whether the use of the drug alongside lifestyle changes showed different outcomes.


Safety and Patient Populations Studied

Research focused on the profile of the drug during short-term use in adults; the studies documented side effects and their severity in participants.

  • Elderly Patients: Studies investigated whether the drug resulted in different outcomes in participants over the age of 65.
  • Pediatric Use: Trials in children under 12 are ongoing. The initial focus has been on the levels of the drug investigated and participant tolerance.
  • Exclusions: One study excluded participants with existing heart conditions. The drug's effects in this population have not been sufficiently studied.

Researchers did not evaluate the process of discontinuing prior treatments.


Combination Therapies and Comparisons

Studies investigated whether combining the drug with a specific dietary supplement resulted in different absorption and bioavailability metrics, with researchers comparing the reported outcomes.

Some studies investigated measurements related to disease progression, comparing outcomes against those of older treatments. These comparisons focused on measuring the rate of symptom recurrence over a 6-month period.

Further research continues to investigate the long-term profile of the drug and is exploring potential additional uses.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Neocalmans Retard (FAQ)


Q: How quickly am I supposed to feel a difference after taking Neocalmans Retard?

Neocalmans Retard is a prolonged-release tablet designed to work over an extended period, not for immediate relief. Official studies indicate that the maximum concentration of the drug in the blood is typically reached between one and five hours after you take the tablet. Due to this sustained-release design, the pain relief effect is intended to be delayed but prolonged.


Q: Is Neocalmans Retard considered habit-forming or addictive?

Regulatory warnings indicate that morphine, the active ingredient, carries a known risk for addiction, abuse, and misuse, even when taken as prescribed. Physical dependence and tolerance are expected biological consequences of chronic use. Management of this treatment is typically conducted under the close supervision of a healthcare provider.


Q: Does Neocalmans Retard affect sleep patterns, like making you drowsy during the day?

Yes, regulatory documents list sedation (drowsiness or sleepiness) as a common side effect of Neocalmans Retard. Regulatory warnings indicate that monitoring for increased sedation is important, particularly when treatment is initiated or dosages are changed.


Q: How long does the effect of one dose of Neocalmans Retard usually last?

The prolonged-release formulation is specifically designed to provide continuous, sustained pain control. According to official dosing principles, the medication is typically administered at 12-hourly intervals and is designed to provide coverage for approximately 12 hours.


Q: What evidence supports the use of Neocalmans Retard in managing chronic conditions?

Official labeling and research evidence indicate that Neocalmans Retard is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. This demonstrates its established use in managing persistent, chronic pain.


Q: Is it true that Neocalmans Retard takes a few weeks to reach its full effect?

The medication does not typically reach its full, stable effect immediately. Official guidelines state that the dosage must be individually adjusted, or 'titrated,' by a healthcare provider over time until effective, sustained pain control is achieved. The timeframe required to achieve stable pain control is highly individual, depending on the dosage adjustments required.


Q: Why do I feel more relaxed a few hours after taking Neocalmans Retard?

The pharmacological action of the drug includes effects that go beyond pure pain relief. The central nervous system action of morphine includes an effect known as anxiolysis (the relief of anxiety) and sedation (sleepiness), which likely contributes to feelings of relaxation.


Q: What are the most common side effects people complain about with Neocalmans Retard?

Regulatory documents list constipation and nausea as the most frequently reported side effects, classified as 'Very Common,' affecting 1 in 10 patients or more. Other common effects include vomiting, dry mouth, sedation, dizziness, and headache.


Q: What is the 'Retard' part of the name supposed to mean?

The term 'Retard' is a medical designation that signifies a sustained-release or prolonged-release formulation. This means the tablet is specifically engineered to slowly and continuously release the active ingredient over an extended period of time.


Q: Is Neocalmans Retard suitable for use during the daytime without causing excessive sleepiness?

Official warnings note that this medication can commonly cause sedation and dizziness. The potential for these side effects means regulatory guidance emphasizes caution regarding activities like driving or operating machinery until the effects of the medication are known.


Q: What’s the difference between Neocalmans Retard and other similar 'calming' supplements or drugs?

Neocalmans Retard is classified as a potent opioid analgesic (narcotic) indicated for severe pain that requires continuous treatment. Its mechanism of action involves specific engagement with the mu-opioid receptors in the central nervous system, which makes it fundamentally different from general calming supplements or non-opioid drugs.


Q: Does Neocalmans Retard affect your ability to drive or operate machinery?

Yes, due to the potential for dizziness, sleepiness, and confusion, regulatory warnings state that engaging in activities that require mental alertness, such as driving or operating heavy machinery, should be avoided until the drug’s effects are fully understood.


Q: If I stop taking Neocalmans Retard, will I experience any withdrawal symptoms?

If physical dependence has developed, abrupt discontinuation can result in serious withdrawal symptoms. Regulatory information states that the dose requires gradual reduction, or 'tapering,' when discontinuing long-term treatment to minimize the risk of these symptoms.


Q: Does Neocalmans Retard need to be taken with food?

Official administration principles state that Neocalmans Retard tablets may generally be taken with or without food.


Q: What are the rare but serious side effects of Neocalmans Retard that I should watch out for?

Serious adverse reactions that require immediate medical attention include Respiratory Depression (slow or difficult breathing), Severe Hypotension (very low blood pressure), and signs of a serious allergic reaction. Official labeling highlights these reactions as critical safety concerns.


Q: Is it possible for Neocalmans Retard to cause mood changes or irritability?

While the drug is primarily known for pain relief and sedation, adverse reaction lists mention potential mental and mood changes. In certain instances, this may involve symptoms like agitation or anxiety, particularly if physical dependence and withdrawal occur.


Q: How is Neocalmans Retard eliminated from the body?

According to official product information, the active ingredient is mainly processed in the liver and then largely excreted from the body through the urine in the form of certain inactive byproducts (metabolites).


Q: What happens if I accidentally take more than the recommended dose of Neocalmans Retard?

An overdose is a medical emergency that can be fatal. Symptoms may include profound sedation, progressing to stupor or coma, severely depressed breathing, and cold or clammy skin. Seeking emergency medical help immediately is required in this situation.


Q: Are there any specific foods or drinks to avoid while using Neocalmans Retard?

Regulatory labeling requires that the use of alcohol be strictly avoided. This is because alcohol can compromise the tablet's prolonged-release design, leading to a rapid and potentially dangerous release of the medication (known as dose dumping).


Q: Does Neocalmans Retard interact with hormonal birth control?

No direct, significant interaction between Neocalmans Retard and hormonal contraceptives (like the pill) is typically documented in the drug's label. However, official sources advise that if the medication causes vomiting, the effectiveness of oral birth control could potentially be reduced.

--UNSAFE

Q: Is it normal to feel a little dizzy when first starting Neocalmans Retard?

Dizziness is listed as a common side effect of the medication. While official documents do not typically specify if this effect is only felt at the start, it is common to experience dizziness as the body adjusts to the drug.


Q: Can teenagers or children use Neocalmans Retard?

Official safety information states that the medicine is strictly contraindicated (forbidden) in infants under one year of age and is not recommended for children under 12 years. Its use and safety have not been sufficiently established for the wider pediatric population.


Q: Does Neocalmans Retard interact with herbal remedies like St. John's Wort?

The regulatory label warns against combining the medication with serotonergic drugs. Although specific herbal remedies may not be listed, it is important to ensure that a healthcare professional is aware of all herbal remedies and supplements being taken alongside this medication.


Q: Does having a history of mental health issues affect who can take Neocalmans Retard?

Regulatory warnings note that individuals with a history of certain mental illnesses (such as major depression) or a history of substance use disorder may be at an increased risk for opioid addiction, abuse, or misuse. These factors are generally considered by a healthcare provider when determining the appropriate treatment plan.


Q: Can I use Neocalmans Retard if I am trying to become pregnant?

Prolonged use of this medication during pregnancy can lead to Neonatal Opioid Withdrawal Syndrome (NOWS) in the newborn. Official information generally reserves the use of this drug during pregnancy for situations where the potential benefit justifies the potential risk.


Q: Are allergic reactions to Neocalmans Retard common?

Hypersensitivity (allergy) to the active substance is listed as a contraindication, meaning the drug should not be used if an allergy is known. However, the most common adverse reactions listed in the regulatory documents are gastrointestinal and central nervous system effects.


Q: What happens if I forget to take a dose of Neocalmans Retard?

Official patient information generally advises to skip the missed dose entirely and then return to the regular dosing schedule. It is important that an individual does not take a double dose to make up for a missed one.


Q: Are there generic versions of Neocalmans Retard available?

The active ingredient in Neocalmans Retard is morphine sulfate. Since morphine is a widely used and established compound, multiple generic and brand-name versions of the prolonged-release formulation are generally available on the market.


Q: Why do some people say Neocalmans Retard helped their anxiety?

The pharmacological action of morphine includes an effect called anxiolysis, which is a state of reduced anxiety. This is a known effect of the central nervous system depression caused by the drug, often observed in addition to its primary function of pain relief.


Q: How can I tell the difference between a minor side effect and a serious problem with Neocalmans Retard?

Official safety labeling clearly distinguishes between common, expected side effects (like nausea or dizziness) and Serious Adverse Reactions (such as severely depressed breathing or signs of a serious allergic reaction). Any Serious Adverse Reaction requires immediate medical attention.


Q: Can I take Neocalmans Retard if I have high blood pressure?

The medication carries warnings that it can cause hypotension (low blood pressure), including a significant drop in blood pressure when standing up (orthostatic hypotension). Official warnings regarding hypotension mean that this factor is typically considered during treatment selection for patients with existing circulatory issues.


Q: Does Neocalmans Retard interact negatively with common cold and flu medicines?

There is a risk of additive central nervous system (CNS) depression when combined with other CNS depressants. This drug class includes certain ingredients found in common cold and flu medicines (e.g., sedating antihistamines), and this combination could cause profound sedation and respiratory depression.


Q: Could Neocalmans Retard make certain medical conditions worse?

Yes, official labeling states the medicine is strictly contraindicated and must not be used in patients with severe respiratory compromise or existing gastrointestinal issues like paralytic ileus. These prohibitions exist because using the drug could dangerously worsen these specific conditions.


Q: Is there a maximum time period you can safely take Neocalmans Retard?

Official dosing principles state that the drug should be used at the lowest effective dosage for the shortest duration necessary. While its indication is for long-term treatment where alternatives are inadequate, the duration of use is ultimately determined by the prescribing clinician based on individual need.


Q: What should I do if the Neocalmans Retard doesn't seem to be working for me?

Regulatory guidance emphasizes that the dosage must be individually adjusted, or 'titrated,' by a healthcare provider over time until sustained pain control is achieved. If the current regimen does not provide sustained pain relief, the treatment plan and dosage require evaluation by the prescribing clinician.

Advertisements

How should Neocalmans Retard be stored and disposed of?

Storage and Disposal of Neocalmans Retard

Storage and disposal of Neocalmans Retard (morphine sulfate prolonged-release) must strictly adhere to regulatory mandates for product stability and controlled substance security.


Official Storage Requirements

The tablets must be stored at controlled room temperature, typically below 25 C, and must be protected from both light and moisture. To maintain the integrity of the prolonged-release formulation, the tablets must be kept in the original, child-resistant container and not be crushed, chewed, or dissolved.


Mandatory Safety and Disposal

It is mandatory to keep this medicine out of the sight and reach of children due to the high risk of fatal accidental ingestion. Unused or expired Neocalmans Retard must not be disposed of in household trash or wastewater. The official instruction is to return the medicine to a drug take-back program or an authorized collection site for proper handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neocalmans Retard found in:

A-Z Index: